Public Defence: Flora Nicol Balieva
MD Flora Nicol Balieva at Institute of Clinical Medicine will be defending the thesis “Psychological burden and life quality in patients with skin diseases. A European study” for the degree of PhD (Philosophiae Doctor).
Photo: Marius Vervik
Trial Lecture – time and place
See Trial Lecture.
- First opponent: Professor Berndt Stenberg, Department of Public Health and Clinical Medicine, Umeå University, Sweden
- Second opponent: Senior Consultant Kjersti Danielsen, Faculty of Health Sciences, The Arctic University of Norway
- Third member and chair of the evaluation committee: Professor Mette Brekke, Faculty of Medicine, University of Oslo
Chair of the Defence
Professor Emeritus Ole Rikard Haavet, Faculty of Medicine, University of Oslo
Associate Professor Florence Dalgard, Skånes University Hospital, Department of Dermatology, Malmö, Lund University, Sweden and Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust
Knowledge of the psychological burden of skin disease in the general dermatological population is scarce.
We collected data on the distribution of skin diseases in Norwegian and European dermatological outpatients by asking consecutive patients and healthy controls to complete standardized questionnaires. We explored the prevalence of psychiatric comorbidity (depression and anxiety) and reduction in life quality. The results can be used to increase health professionals’ awareness of the specific needs of these patients for providing optimal health care.
The thesis shows in its first part the high association between skin disease and psychiatric comorbidity, especially in Norwegian patients, where depression and anxiety are higher than in the other participating European countries.
In its second part, the thesis confirms the large impact skin conditions have on patients’ wellbeing, differentiating between different aspects and domains of HRQoL.
Patients with skin diseases reported reduced HRQoL comparable to patients with chronic obstructive lung disease, diabetes mellitus, cardio-vascular disease and cancers. These findings are important in the prioritization of resource allocation between medical fields and within dermatological sub-specialities.
Finally, we show that treatments for skin diseases also contribute considerably to reducing HRQoL, even for diseases that do not impact HRQL significantly (such as skin cancer): the burden of dermatological treatment should be considered when planning therapy, designing instruments for evaluating HRQoL and when evaluating new dermatological therapeutic options.
Contact the research support staff.